Oncogenerix USA, Inc. v. Pharma Resources GmbH
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 ONCOGENERIX USA, INC., a Case No.: 22-CV-1313 TWR (AHG) California corporation,
ORDER DISCHARGING ORDER TO
Plaintiff, SHOW CAUSE v. 14 (ECF Nos. 5, 7) PHARMA RESOURCES GMBH; and 15 DOES 1 through 10, inclusive, 16 Defendants.
Presently before the Court is Plaintiff Oncogenerix USA, Inc.’s Response (ECF No. 7, “Resp.”) to the Court’s November 15, 2022, Order to Show Cause Why this Action Should Not be Dismissed for Lack of Subject-Matter Jurisdiction (ECF No. 5, “OSC”). Having reviewed Plaintiff’s Response and other relevant law, the Court is now satisfied that it has subject-matter jurisdiction over this action. Plaintiff filed a Complaint seeking declaratory relief. (ECF No. 1, “Compl.”) Plaintiff asks the Court to find that Plaintiff is not required to participate in an arbitration that Defendant Pharma Resources GmbH initiated relating to a $440,000 debt that Plaintiff allegedly owes. (Id. ¶¶ 12, 32). The Court harbored doubt about its…